Supplements
Cardiovascular disease
Vol. 451, No. 7181 pp 903–957
In this supplement
Cardiovascular disease is the most common cause of death worldwide and will become even more prevalent as the population ages. New therapeutic targets are being identified as a result of emerging insights into disease mechanisms, and new strategies are also being tested, possibly leading to new treatment options. Improving diagnosis is also crucial, because by detecting disease early, the focus could be shifted from treatment to prevention.
Editorial
Cardiovascular disease
Michael Basson
doi:10.1038/451903a
Top of page
Reviews
Translating molecular discoveries into new therapies for atherosclerosis
Daniel J. Rader & Alan Daugherty
doi:10.1038/nature06796
Abstract | Full Text | PDF (1,912KB)
Triggers, targets and treatments for thrombosis
Nigel Mackman
doi:10.1038/nature06797
Abstract | Full Text | PDF (1,104KB)
Tackling heart failure in the twenty-first century
James O. Mudd & David A. Kass
doi:10.1038/nature06798
Abstract | Full Text | PDF (1,173KB)
A genetic framework for improving arrhythmia therapy
Björn C. Knollmann & Dan M. Roden
doi:10.1038/nature06799
Abstract | Full Text | PDF (673KB)
Stem-cell therapy for cardiac disease
Vincent F. M. Segers & Richard T. Lee
doi:10.1038/nature06800
Abstract | Full Text | PDF (2,410KB)
The developmental genetics of congenital heart disease
Benoit G. Bruneau
doi:10.1038/nature06801
Abstract | Full Text | PDF (329KB)
Top of page
Progress
The search for new cardiovascular biomarkers
Robert E. Gerszten & Thomas J. Wang
doi:10.1038/nature06802
Abstract | Full Text | PDF (217KB)
Imaging of atherosclerotic cardiovascular disease
Javier Sanz & Zahi A. Fayad
doi:10.1038/nature06803
Abstract | Full Text | PDF (2,567KB)